Pro Medicus is up 100% since the buy signal back in July 2020.
While the stock trades on a very high multiple 100x FY22 earnings, the 40%+ revenue and profit growth is supported by long-term contract wins. Watch for buying interest to build within the range indicated.
![](https://d2cbr21qzf932u.cloudfront.net/wp-content/uploads/2022/01/PME-1-1024x608.png)